These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23304464)

  • 1. The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome.
    Muhidin SO; Magan AA; Osman KA; Syed S; Ahmed MH
    J Obes; 2012; 2012():637538. PubMed ID: 23304464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease and colorectal cancer.
    Mikolasevic I; Orlic L; Stimac D; Hrstic I; Jakopcic I; Milic S
    Postgrad Med J; 2017 Mar; 93(1097):153-158. PubMed ID: 27852946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?
    Ahmed MH; Barakat S; Almobarak AO
    J Obes; 2012; 2012():483135. PubMed ID: 23320150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
    Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
    Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between non-alcoholic fatty liver disease and colorectal cancer.
    Parizadeh SM; Parizadeh SA; Alizade-Noghani M; Jafarzadeh-Esfehani R; Ghandehari M; Mottaghi-Moghaddam A; Goldani F; Khazaei M; Ghayour-Mobarhan M; Ferns GA; Hassanian SM; Avan A
    Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):633-641. PubMed ID: 31092057
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
    Manco M
    J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
    Katsiki N; Perez-Martinez P; Anagnostis P; Mikhailidis DP; Karagiannis A
    Curr Vasc Pharmacol; 2018; 16(3):219-227. PubMed ID: 28669328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
    El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
    Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.
    Simon TG; Corey KE; Chung RT; Giugliano R
    Dig Dis Sci; 2016 Dec; 61(12):3425-3435. PubMed ID: 27714510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome and nonalcoholic fatty liver disease in children.
    Sundaram SS; Zeitler P; Nadeau K
    Curr Opin Pediatr; 2009 Aug; 21(4):529-35. PubMed ID: 19444112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm.
    Pan S; Hong W; Wu W; Chen Q; Zhao Q; Wu J; Jin Y
    Medicine (Baltimore); 2017 Jan; 96(2):e5809. PubMed ID: 28079806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome.
    Rhee EJ; Kim MK; Park SE; Park CY; Baek KH; Lee WY; Kang MI; Park SW; Kim SW; Oh KW
    Endocr J; 2013; 60(6):743-52. PubMed ID: 23411507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation of risk factors between metabolic syndrome and nonalcoholic fatty liver disease in children and adolescents].
    Smolka V; Ehrmann J; Tkachyk O; Zápalka M
    Cas Lek Cesk; 2014; 153(2):91-7. PubMed ID: 24797780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].
    Graffigna MN; Belli SH; de Larrañaga G; Fainboim H; Estepo C; Peres S; García N; Levalle O
    Acta Gastroenterol Latinoam; 2009 Mar; 39(1):30-7. PubMed ID: 19408737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
    Lim S; Taskinen MR; Borén J
    Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
    Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
    Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nonalcoholic fatty liver disease as a risk factor of macroangiopahty in patients with type 2 diabetes].
    Trojak A; Idzior-Waluś B
    Przegl Lek; 2012; 69(12):1276-9. PubMed ID: 23750438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.